18F-choline PET/CT for distant metastases at early stage of prostate cancer recurrence (PSA< 2 ng/ml), when local salvage radiotherapy is intended

被引:0
|
作者
Cimitan, M. [1 ]
Bagatin, E. [1 ]
Bortolus, R. [2 ]
Canzonieri, V. [3 ]
Morassut, S. [4 ]
Borsatti, E. [1 ]
Trovo, M. [2 ]
机构
[1] Natl Canc Inst CRO IRCCS Aviano, Div Nucl Med, Aviano, PN, Italy
[2] Natl Canc Inst CRO IRCCS Aviano, Div Radiotherapy, Aviano, PN, Italy
[3] Natl Canc Inst CRO IRCCS Aviano, Div Pathol, Aviano, PN, Italy
[4] Natl Canc Inst CRO IRCCS Aviano, Div Radiol, Aviano, PN, Italy
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S157 / S157
页数:1
相关论文
共 50 条
  • [41] Role of 18F-choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer
    Chondrogiannis, Sotirios
    Marzola, Maria Cristina
    Ferretti, Alice
    Maffione, Anna Margherita
    Rampin, Lucia
    Grassetto, Gaia
    Nanni, Cristina
    Colletti, Patrick M.
    Rubello, Domenico
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (09) : 1356 - 1364
  • [42] Role PSA kinetics in the detection rate of 18F-Choline PET/CT in restaging prostate cancer patients
    Chondrogiannis, S.
    Marzola, M. C.
    Rampin, L.
    Grassetto, G.
    Pavan, L.
    Maffione, A. M.
    Rubello, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S500 - S500
  • [43] Role of 18F-Choline PET/CT in suspicion of relapse following definitive radiotherapy for prostate cancer
    Marzola, M. C.
    Chondrogiannis, S.
    Ferretti, A.
    Maffione, A. M.
    Rampin, L.
    Grassetto, G.
    Rubello, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S286 - S287
  • [44] Therapeutic implications of 18F-PSMA PET/MRI in patients with prostate cancer and biochemical recurrence (PSA < 2 ng/ml) after prostatectomy
    Garcia, J.
    Compte, A.
    Kauak, M.
    Bassa, P.
    Blanch, T.
    Pastor, J.
    Riera, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S526 - S527
  • [45] Prostate cancer isolated local recurrence diagnosed by 18F-Choline PET/CT and/or MRI, confirmed by biopsies and leading to salvage therapy in 22 consecutive patients
    Champion, L.
    Wartski, M.
    Jehanno, N.
    Servois, V.
    Abdelli, O.
    Hottelart, A.
    Edeline, V.
    Pontvert, D.
    Meria, P.
    Alberini, J.
    Petras, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S471 - S471
  • [46] PET/CT with 18F-choline after radical prostatectomy in patients with PSA ≤2 ng/ml. Can PSA velocity and PSA doubling time help in patient selection?
    Agostino Chiaravalloti
    Daniele Di Biagio
    Mario Tavolozza
    Ferdinando Calabria
    Orazio Schillaci
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 1418 - 1424
  • [47] 18F-fluciclovine PET/CT detection of biochemical recurrent prostate cancer in patients with PSA levels <2.00 ng/mL
    Garza, Daniel
    Kandathil, Asha
    Xi, Yin
    Subramaniam, Rathan M.
    NUCLEAR MEDICINE COMMUNICATIONS, 2021, 42 (08) : 907 - 913
  • [48] PET/CT with 18F-choline after radical prostatectomy in patients with PSA ≤2 ng/ml. Can PSA velocity and PSA doubling time help in patient selection?
    Chiaravalloti, Agostino
    Di Biagio, Daniele
    Tavolozza, Mario
    Calabria, Ferdinando
    Schillaci, Orazio
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (08) : 1418 - 1424
  • [49] 18F-Choline PET/CT in early re-staging of prostate cancer patients at high-risk for recurrence
    Cimitan, M.
    Canzonieri, V.
    Bortolus, R.
    Morassut, S.
    Baresic, T.
    Bagatin, E.
    Borsatti, E.
    Garbeglio, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S295 - S295
  • [50] Impact of 18F-Choline PET/CT in Prostate Cancer Patients with Biochemical Recurrence: Influence of Androgen Deprivation Therapy and Correlation with PSA Kinetics
    Beheshti, Mohsen
    Haim, Silke
    Zakavi, Rasoul
    Steinmair, Martin
    Waldenberger, Peter
    Kunit, Thomas
    Nader, Michael
    Langsteger, Werner
    Loidl, Wolfgang
    JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (06) : 833 - 840